Macquarie Group LTD Adverum Biotechnologies, Inc. Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.74 - $2.4 $2,968 - $4,094	-1,706 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.26 - $14.36 $4,722 - $7,323	-510 Reduced 23.01%	1,706 $17,000
Q2 2020 Aug 11, 2020	BUY	$8.53 - $25.64 $18,902 - $56,818	2,216 New	2,216 $46,000
Q1 2018 May 11, 2018	SELL	$3.65 - $7.95 $8,749 - $19,056	-2,397 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$2.85 - $3.95 $6,831 - $9,468	2,397	2,397 $8,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.